Mass. Biotech Co. Hit With Stock Drop Suit Over New Drug
Massachusetts-based biotechnology company Aldeyra Therapeutics Inc. was hit with a proposed class action Monday by investors who claim the company and its top executives made false and misleading statements about a...To view the full article, register now.
Already a subscriber? Click here to view full article